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Saccharide-RNA recognition in an aminoglycoside 
antibiotic-RNA aptamer complex 
Licong Jiang, Asif K Suri, Radovan Fiala and Dinshaw J Pate1 
Background: Aminoglycoside antibiotics are known to target ribosomal, retroviral 
and catalytic RNAs with high affinity and specificity. Recently, in vitro selection 
experiments have identified RNA aptamers that bind to aminoglycoside antibiotics 
with nanomolar affinity and stringent specificity, allowing discrimination between 
closely related family members. There has, to date, been limited structural 
information on the molecular basis of such saccharide-RNA recognition. 
Results: We describe a solution-structure determination of the tobramycin-RNA 
aptamer complex, obtained using NMR and molecular dynamics. The structure 
gives insight into the molecular features associated with saccharide-RNA 
recognition. Tobramycin adopts a defined alignment and binds to the RNA major 
groove centered about a stem-loop junction site. A portion of the bound 
tobramycin is encapsulated between the floor of the major groove and a 
looped-out cytosine residue that forms a flap over the binding site in the complex. 
Conclusions: The emergence of antibiotic-resistant pathogens and their impact 
on human health continues to be a major concern in the medical community. 
Rational modification of existing antibiotics aimed at improving their efficacy 
requires a molecular view of their receptor-binding sites. We have provided such 
a molecular view for a member of the aminoglycoside antibiotic family that 
targets RNA. 
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Introduction 
The mode of action of antimicrobial aminoglycoside 
antibiotics (reviewed in [l,Z]) has been of great interest 
ever since these antibiotics were shown to be able to block 
protein synthesis (reviewed in [3,4]). It soon became 
apparent that aminoglycoside antibiotics target specific 
sites on RNA, ranging from functional sites on 16s ribo- 
somal RNA [5,6] and catalytic group I intron RNA [7,8], to 
the rev response element in HIV RNA [9] and the 
hammerhead ribozyme RNA [lo]. There is limited infor- 
mation available that describes, in molecular terms, the 
principles associated with sequence/structure-specific 
recognition of RNA binding sites by the aminoglycosidic 
antibiotics. Recent developments in in vitro selection 
methods have resulted in the identification of RNA 
sequences that target aminoglycoside antibiotics with high 
affinity and specificity [ 1 l-131. The aminoglycoside 
antibiotics include neomycin [13], tobramycin [ll], 
lividomycin and kanamycin [12], and the selected RNA 
aptamers can discriminate between closely related family 
members. We have focused on the complex formed 
between tobramycin [13,14] (Fig. la) and its RNA 
aptamer (Fig. lb) which has a dissociation constant (KJ in 
the nanomolar range [ll]. We have undertaken an 
NMR-molecular dynamics study of the tobramycin-RNA 
aptamer complex and report below on the structure of 
the complex in solution. The structure defines the fold 
of the bulge-containing stem-loop RNA aptamer and 
tobramycin in the complex and gives insight into the 
recognition elements responsible for the high affinity 
sequence/structure specific complex formation. 
Results 
Complex formation 
We followed formation of the tobramycin-RNA aptamer 
complex by monitoring the imino protons of the RNA 
aptamer upon gradual addition of tobramycin. The imino 
proton spectra (8515.5 ppm) of the free RNA aptamer 
and the 1:l complex with bound tobramycin in I-I,0 
buffer (10 mM phosphate), pH 6.8 at 5°C are plotted in 
Figure 2a and Zb, respectively. We detect separate imino 
proton resonances for the free and bound RNA aptamer at 
substoichiometric ratios, indicating slow exchange due to 
the formation of a high affinity complex. Imino proton res- 
onances that are broad in the free RNA aptamer (Fig.2a) 
sharpen and shift on formation of the tobramycin-RNA 
aptamer complex (Fig. 2b). 
Exchangeable nucleic acid protons 
The exchangeable imino protons have been assigned on 
the basis of analysis of a series of multinuclear multidimen- 
sional NMR experiments on tobramycin complexed to 
unlabeled and uniformly 13C,lsN-labeled RNA aptamers in 
H,O buffer solution. These included nuclear Overhauser 
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Tobramycin and the 27-nucleotide RNA aptamer. (a) Chemical formula 
and numbering system of tobramycin. The amine protons are positively 
charged through protonation at pH 6.8. (b) Sequence and numbering 
system of the 27-nucleotide RNA aptamer. 
effect spectroscopy (NOESY), lH-15N heteronuclear single 
quantum coherence (HSQC), two-dimensional versions of 
lH-15N hetero multiple quantum coherence (HMQC)- 
NOESY and lH-13C HMQC- NOESY and ‘H-13C-15N 
HCCNH-total correlation spectroscopy (TOCSY) experi- 
ments. An expanded NOESY (150 ms mixing time) contour 
plot of the unlabeled complex outlining NOES in the sym- 
metrical imino proton region (9.0-150ppm) in H,O buffer 
at 0°C is plotted in Figure 3a. We can trace NOES between 
imino protons on adjacent base pairs along the stem of the 
helix and into the hairpin loop (UlO-Ull-U12 segment) of 
the RNA aptamer in the complex (Fig. 3a). Unfortunately, 
the imino protons of G8 and G9 of the G*C base pairs that 
flank the Al9 bulge are superpositioned at 1320ppm in the 
imino proton spectrum of the complex (Fig. 3b). 
We made two analogs of the RNA aptamer in which the 
G8*C20 pair was replaced either by the 18*C20 pair or the 
A8*U20 pair, and we recorded one- and two-dimensional 
NMR spectra of these RNA aptamer analog complexes. 
The imino proton spectra establish that both aptamer 
analogs form high affinity complexes. The imino proton of 
18 of the 18*CZO pair resonates at 15.11 ppm with a some- 
what broadened line width, whereas the imino proton of 
U20 of the A8*U20 pair is too broad to be detectable in the 
spectra of the complex. This suggests that the base pair at 
the 8.20 position is less stable than its counterpart at the 
9*18 position in the complex, possibly reflecting the con- 
tribution of the Al9 bulge base that is flanked by these 
base pairs in the sequence of the RNA aptamer. The imino 
protons of G8 (13.20 ppm) and G9 (13.28 ppm) are partially 
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Formation of the tobramycin-RNA aptamer complex. lmino proton 
NMR spectra (8.5-l 5.5 ppm) of (a) the 27-nucleotide RNA aptamer 
and (b) the tobramycin-RNA aptamer complex in H,O buffer (10 mM 
phosphate) at pH 6.8 and 5°C. The imino proton assignments are 
indicated over the spectra. 
resolved when the bulged Al9 residue is replaced by its 
G19 purine counterpart and this substitution has no effect 
on complex formation as monitored in the imino proton 
spectral region. The complex can also form when G14 is 
replaced by Al4 and when Cl5 is replaced by A15, as mon- 
itored by the imino proton spectra in the tobramycin-RNA 
aptamer analog complexes. These studies on the five RNA 
aptamer analogs which bind tobramycin with the same 
sequence specificity and similar high affinity confirm thl: 
imino proton assignments in the free RNA aptamer and 
the tobramycin-RNA aptamer complex that are indicated 
over the resonances in Figure 2a and b, respectively. 
The imino protons can also be linked to their attached 
nitrogens by recording lH-15N HSQC spectra on the 
complex made up of tobramycin and labeled RNA aptamer 
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Assignment of exchangeable nucleic acid protons. (a) An expanded 
NOESY (150 ms mixing time) contour plot of the symmetrical imino 
proton region (9.0-l 5.0ppm) of the tobramycin-RNA aptamer complex 
in H,O buffer solution, pH 6.8 at 0%. The lines trace the NOE connec- 
tivities between imino protons on adjacent base pairs along the stem 
segments of the RNA aptamer in the complex. (b) An expanded contour 
plot of a two-dimensional version of the lH-l5N HMQC-NOESY 
(150 ms mixing time) experiment identifying correlations between imino 
protons and attached nitrogens in the tobramycin-‘sC,‘5N-labeled RNA 
aptamer complex in H,O buffer solution, pH 6.8 at 0%. The lines trace 
the connectivities between adjacent base pairs along the stem 
segments of the RNA aptamer in the complex. 
in H,O buffer. The uracil and guanine imino nitrogens 
have distinct chemical shifts, allowing a straightforward dif- 
ferentiation between the uracil and guanine imino protons 
in the complex. The two-dimensional version of the 
lH-‘“N HMQC-NOESY experiment permits a sequential 
walk between imino protons on adjacent base pairs in the 
stem and adjacent bases in the loop as outlined in the 
expanded contour plot for the tobramycin-i%,1.5N-labeled 
RNA aptamer complex in H,O buffer at 0°C (Fig. 3b). 
Base-pairing alignments 
The pairing alignments for stem base pairs - (Gl-G8). 
(CZO-(2’27) and (G9-UlO)*(A17-C18) - can be readily 
characterized by NOE patterns that monitor connectivities 
across the base pair in the helix. Watson-Crick alignments 
are characterized by an NOE between the uracil imino 
and adenine HZ protons across A*U base pairs and by 
NOES between the guanine imino and cytosine amino 
protons across G*C base pairs in the stem segments. We 
can readily monitor these patterns within the stem seg- 
ments for all base pairs in the complexes of tobramycin 
with the RNA aptamer and its analogs, establishing 
Watson-Crick alignment along the entire stem of the RNA 
in the complex. The imino protons of G8 and G9 are 
reserved in the RNA-aptamer analog, containing a G19 for 
Al9 substitution, and the data establish that the G8*C20 
and G9*C18 pairs also form a Watson-Crick alignment. 
The above analysis was aided by our ability to distinguish 
between purine H8 and HZ protons by recording a two- 
dimensional version of the lH-13C HMQC-NOESY exper- 
iment on the tobramycin-13C,‘5N-labeled RNA aptamer 
complex, and using the large chemical shift difference 
between purine C8 and C2 carbons to make the distinction. 
RNA sugar 2’.hydroxyl protons 
We have also recorded and compared one-dimensional 
and two-dimensional NOESY spectra with and without 
broadband 13C and ‘“N decoupling, to differentiate 
between RNA protons bound to carbon, nitrogen and 
oxygen in the tobramycin-‘3C,1sN-labeled RNA aptamer 
complex in H,O buffer solution. Such experiments have 
permitted us to assign the narrow exchangeable proton at 
9.36 ppm to a sugar Z-OH proton that has been assigned 
to U12 based on its through-space (NOESY) and through- 
bond (TOCSY) connectivities (to the nonexchangeable 
sugar protons of LJ12) in the complex. 
Correlation of exchangeable and nonexchangeable nucleic 
acid protons 
NMR methods have been developed recently that permit 
the through-bond correlation of the exchangeable imino 
protons with nonexchangeable base protons within indi- 
vidual guanine and uracil rings in RNA and ligand-RNA 
complexes [15--171. Expanded plots of the HCCNH- 
TOCSY experiment outlining through-bond correlations 
between uracil imino protons and either uracil HS/H6 
protons or uracil C6 carbons in the complex are shown 
in Figure 4a and 4b, respectively. Weaker correlations 
are also observed between guanine imino protons and 
HS protons/ C8 carbons in this experiment (Fig. 4a,b), 
with these correlations being more clearly detected for 
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Through-bond correlation between 
exchangeable and nonexchangeable nucleic 
acid protons. Expanded contour plots of 
HCCNH-TOCSY experiments on the 
tobramycin-13C,15N-labeled RNA aptamer 
complex in H,O buffer solution, pH 6.8 at 
10°C. These experiments were optimized for 
the uracil imino proton region and correlate 
uracil imino protons with (a) their own H5 and 
H6 protons and (b) C6 carbons. Weaker 
cross peaks are also observed for correlations 
between the guanine imino protons and (a) 
their own H8 protons or (b) C8 carbons. The 
following changes were made in the 
HCCNH-TOCSY experiment to optimize for 
uracil relative to our previous optimization for 
guanine [15]: the 13C frequency was set to 
137 ppm; the 13C TOCSY transfer was 
achieved by a DIPSI- spin lock applied at a 
power of 9.5 kHz for 17 ms; a 650 ms 
REBURP pulse was used as the selection 
pulse on 1%; a constant time version of the 
experiment was used for the 1 H-13C 
correlation with a 15 ms constant time 
evolution period on carbon. 
HCCNH-TOCSY experiments optimized for guanine 
imino protons in the complex. The through-bond cor- 
relations between exchangeable and nonexchangeable 
protons within individual uracils and guanines are essen- 
tial for linking exchangeable and nonexchangeable proton 
assignments in the complex. 
Nonexchangeable nucleic acid protons 
The nonexchangeable base and sugar protons of the 
tobramycin-RNA aptamer complex have been assigned 
following analysis of multinuclear multidimensional 
(NOESY, COSY, TOCSY, lH-13C NOESY-HMQC and 
lH-l3C HCCH-COSY and HCCH-TOCSY) data sets in 
D,O solution. The NOE cross-peaks are reasonably well 
resolved in expanded NOESY contour plots, correlating 
the base protons with their own and 5’-flanking sugar Hl’ 
protons in the complex in D,O buffer, at pH 6.8 and 25°C. 
These connectivities are traced for the A7-U21 segment 
in Figure 5a, with the connectivities either weak or absent 
at the UlZ-A13, G14-Cl5 and Cl&A19 steps, indicating 
structural discontinuities at these steps in the complex. 
The connectivities can be independently assigned with 
additional confidence following dispersion of the two- 
dimensional data into a third heteronuclear dimension 
according to the chemical shifts of the attached carbons. 
This has been achieved by analyzing the lH-13C 
NOESY-HMQC spectra of the tobramycin-13C,15N- 
labeled RNA aptamer complex in Da0 buffer at 25”C, as 
shown in strip plots illustrating sequential connectivities 
from A7 to U21 in Figure 5b. We also note weak or absent 
connectivities at the UlZ-Al?., G14-Cl.5 and Cl%A19 
steps in this data set, as well as connectivities between 
non-adjacent U12 and G14 residues and between non- 
adjacent G14 and G16 residues in the complex (Fig. Sb). 
The H8 proton of Al9 has an unusual downfield shift of 
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Figure 5 
Assignment of nonexchangeable nucleic acid 
protons. (a) An expanded NOESY (300 ms 
mixing time) contour plot identifying NOES 
between the base protons (7.0-8.6 ppm) and 
the sugar Hl’ protons (4.3-6.5 ppm) of the 
tobramycin-RNA aptamer complex in D,O 
buffer, pH 6.8 at 25°C. The lines trace the 
NOE connectivities between the base and its 
own and 5’-flanking sugar H 1’ protons for the 
A7 to U21 segment. The strong H5-H6 NOE 
cross-peaks of the uracils and the cytosines 
are designated by asterisks. (b) A plot of two 
dimensional 1 H-1 H spectral strips at specific 
purine C8/pyrimidine C6 carbon chemical 
shift values taken from the three-dimensional 
l H-‘sC NOESY-HMQC (300 ms mixing time) 
experiment on the tobramycin-13C,15N- 
labeled RNA aptamer complex in D,O buffer 
solution, pH 6.8 at 25%. The lines trace 
NOE connectivities between base protons 
and their own and 5’-flanking sugar H 1’ 
protons from A7-U21. 
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8.54 ppm, the H5 proton of Cl.5 has an unusual downfield These data provide a complete set of base and sugar 
shift of 6.07 ppm and the Hl’ proton of U16 has an unusual Hl’ proton assignments in the tobramycin-RNA aptamer 
upfield shift of 4.38ppm in the proton spectra of the complex. The remaining sugar protons can be linked 
complex. Furthermore, we observe a strong NOE between through coupling connectivities starting from the sugar Hl’ 
the H6 and Hl’ protons of Cl5 in a short mixing-time protons in ‘H--r% HCCH-COSY and HCCH-TOCSY 
NOESY data set [18] for this residue in the complex. experiments resulting in the assignment of the majority of 
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the nonexchangeable sugar proton and attached carbon 
chemical shifts in the tobramycin-13C,1SN-labeled RNA 
aptamer complex at 25°C. Furthermore, the H8 and HZ 
nonexchangeable base protons of individual adenine 
residues have been linked as the result of a two-dimen- 
sional version of the rH-13C HCCH-TOCSY experiment 
on the complex at 25°C. 
We have monitored through-bond proton connectivities 
between sugar Hl’ and HZ’ protons to qualitatively distin- 
guish between CZ’-endo (large coupling constant) and C3’- 
endo (negligible coupling constant) families of sugar pucker 
geometries in the tobramycin-RNA aptamer complex. We 
observe strong Hl’-HZ’cross-peaks for Cl.5 and A19, imply- 
ing sugar puckers in the C’Z’-endo range for these residues 
in the complex. In addition, weak coupling cross-peaks are 
observed for the Al7 and Cl8 residues in the complex. 
Cross-strand interactions in the RNA hairpin loop 
A set of cross-strand NOES are observed within the 
Ull-U12-A13-G14-C15-U16 segment of the hairpin 
loop in the tobramycin-RNA aptamer complex. A strong 
NOE is observed between the imino protons of Ull and 
U16 and a weaker NOE observed between the imino 
protons of U12 and U16 across the RNA hairpin loop in 
the complex (Fig. 3a). In addition, cross-strand NOES are 
observed between the protons of UlZ and G14, including 
one between the Z-OH of U12 and the H8 proton of G14 
and another between the Hl’ proton of U12 and the H8 
proton of G14 (Fig. 5a) in the complex. These cross-strand 
NOES provide critical restraints for defining the conforma- 
tion of the hairpin loop in the complex. 
Phosphate backbone 
We observe several phosphorus resonances shifted outside 
the -3.8 to -4.7 ppm range, characteristic of unperturbed 
backbone phosphates in the proton-decoupled phospho- 
rus NMR spectrum of the tobramycin-RNA aptamer 
complex in D,O buffer at 25°C. These phosphorus reso- 
nances have been assigned on the basis of analysis of 
proton-detected multinuclear multidimensional (lH-“lP 
and 1H-13C-31P) correlation experiments on the complex. 
Large downfield phosphorus chemical shifts are observed 
at the A13-G14 (-259ppm), A19-C20 (-2.36ppm) and 
UlZ-A13 (-1.40ppm) steps, whereas a large upfield shift 
is observed at the G14-Cl5 (-6.05ppm) step, suggesting 
there are conformational perturbations in the backbone for 
the UlZ-A13-G14-Cl5 segment of the hairpin loop and 
the A19-C20 step at the bulge site in the complex. 
Tobramycin protons 
Tobramycin consists of a central non-sugar ring, deoxy- 
streptamine (labeled I in Fig. la), attached through glyco- 
sidic linkages in either direction to amino sugars, Z-amino- 
3-deoxy-6-aminoglucose and 3-aminoglucose (labeled II 
and III, respectively, in Figure la). The proton NMR 
spectra of free tobramycin have been recorded and analyzed 
in aqueous solution [19], and crystal structures are available 
for the related aminoglycoside antibiotic kanamycin both 
in the free state [ZO] and when bound to kanamycin 
nucleotidyltransferase [Zl]. 
We have differentiated between the protons of rings I, II 
and III of tobramycin (Fig. la) in its complex with the 
RNA aptamer. Rings II and III are amino sugars and 
hence distinct from non-sugar ring I in the tobramycin 
molecule. Furthermore, ring II contains methylene 
protons at position 3’ (Fig. la), while ring III lacks methyl- 
ene protons making it possible to differentiate between 
tobramycin rings II and III on the basis of their patterns of 
through-bond and through-space connectivities in the 
complex. The NOE connectivities from the Hl’ proton of 
ring II and the Hl” proton of ring III are outlined in the 
NOESY (300ms mixing time) contour plot of the 
tobramycin-RNA aptamer complex in D,O buffer at 25°C 
in Figure 6a, and these patterns have been confirmed 
using the corresponding 13C-filtered NOESY data on the 
tobramycin-13C,1sN-labeled RNA aptamer complex. 
The H4 and H6 protons of tobramycin non-sugar ring I are 
in similar chemical environments and have been assigned 
based on NOES between the Hl’ proton of ring II and the 
H4 proton (and to a lesser extent H6 proton) of ring I, and 
between the Hl” proton of ring III and the H6 proton 
(and to a lesser extent H4 proton) of ring I in NOESY 
spectra, recorded as a function of mixing time on the 
complex. The Hl and H3 protons of tobramycin ring I are 
also in similar chemical environments and are separated 
by methylene protons at position 2 (Fig. lb). These 
tobramycin non-sugar ring I protons exhibit resolved 
chemical shifts for the H4 (4.01 ppm) and H6 (3.81 ppm) 
protons and resolved chemical shifts for the Hl (3.78 ppm) 
and H3 (3.93 ppm) protons in the complex. 
A few tobramycin exchangeable protons can be observed 
and assigned in the NMR spectrum of the complex on the 
basis of NOE and coupling connectivities to adjacent 
nonexchangeable protons. These include the Z/-NH,+ 
(7.40ppm) proton on ring II, the l-NH,+ (8.11 ppm) and 5- 
OH (7.03ppm) protons on ring I and the 4”-OH 
(7.19ppm) and 6”-OH (7.58 ppm) protons on ring III in 
the complex (Fig. 6b). 
Intermolecular NOES in the complex 
We have identified 34 intermolecular NOES between 
tobramycin and the RNA aptamer in the complex (Table 
1). The observed degeneracy in several of the tobramycin 
proton chemical shifts complicated the assignment of 
intermolecular NOES in the complex. Thus, the H6 proton 
on ring I and the HZ” proton on ring III exhibit the same 
chemical shift of 3.81 ppm in the complex. The inter- 
molecular NOE between the 3.81 ppm resonance and the 
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Assignment of tobramycin exchangeable and nonexchangeable 
protons. (a) An expanded NOESY (300ms mixing time) contour plot 
correlating NOES between the 4.9-6.5 ppm region and the 
1.6-4.4 ppm region of the tobramycin-RNA aptamer complex in D,O 
buffer solution, pH 6.8 at 26% This plot outlines NOES originating in 
the tobramycin amino sugar ring II anomeric Hl’ proton and amino 
sugar ring Ill anomeric Hl” proton, as well as NOES originating in the 
RNA Cl 5(Hl’) and Ul O(H5) protons in the complex. The cross-peaks 
are labeled by their tobramycin nonexchangeable proton assignments 
in the complex. (b) An expanded NOESY (200 ms mixing time) contour 
plot correlating NOES between the 5.8-9.0 ppm region and the 
1.4-4.0 ppm region of the tobramycin-RNA aptamer complex in H,O 
buffer solution, pH 6.8 at 5°C. This plot outlines NOES originating in 
the tobramycin and RNA exchangeable protons in the complex. The 
cross-peaks are labeled by their tobramycin nonexchangeable proton 
assignments in the complex. 
H5 proton of UlO is tentatively assigned to an NOE 
between ring-I(H6) and UlO(H.5), because an unambiguous 
Intermolecular NOEs between tobramycin and RNA aptamer 
protons in the complex. 
Tobramycin Chemical shifts RNA 
ring I 
Hl 
H2a 
H3 
H4 
H5 
H6 
ring II 
H2’ 
2’-NH, 
H3’a 
ring Ill 
Hl” 
H2” 
H3” 
H4” 
4”-OH 
H5” 
H6” 
H6” 
6”.OH 
3.78 ppm 
1.71 ppm 
3.93 ppm 
4.01 ppm 
3.45 ppm 
3.81 ppm 
3.74 ppm 
7.40 ppm 
1.56 ppm 
5.23 ppm 
3.81 ppm 
3.60 ppm 
3.33 ppm 
7.19 ppm 
3.76 ppm 
3.94 ppm 
3.06 ppm 
7.58 ppm 
Ul O(H5) 
Ul O(H5), G9(H8) 
UlO(H5) 
Ul O(H5) 
UlO(NH3,H5), Ul 1 (NH3), 
Al 7(NH,-6b, e) 
Ul O(H5) 
U12(NH3) 
Ul 1 (NH3), U12(NH3) 
U12(NH3) 
Cl 5(H5) 
Cl 5(H5, Hl’) 
Al 9(H2), Cl 8(NH,-4b, e) 
Cl 5(H5, H6), C18(NH,-4e) 
Cl 8(NH,-4b, e) 
Cl 5(H5) 
C15(H5, Hl’) 
Cl 5(H5, H6, Hl ‘) 
Al 7(NH,-6b, e) 
NOE was also observed between ring-I(H5) and UlO(H5) 
in the complex (Table 1). 
Tobramycin amino sugar ring III exhibits the most inter- 
molecular NOES, whereas amino sugar ring II exhibits the 
least. intermolecular NOES in the tobramycin-RNA 
aptamer complex (Table 1). Significantly, protons on ring 
III exhibit many intermolecular NOES to the base (H.5 
and H6) and sugar (Hl’) protons of Cl5 in the complex. 
The majority of the intermolecular NOES involving non- 
sugar ring I protons are to the base H5 proton of UlO in 
the complex. The only assignable intermolecular NOES 
involving protons on ring II are to the imino protons of 
Ull and U12 in the complex. 
Input restraints 
Inter-proton distance restraints were quantified from 
NOE buildup curves in NOESY experiments on the 
tobramycin-RNA aptamer complex in Ha0 (two mixing 
times) and D,O (four mixing times) buffer solutions. Addi- 
tional distance restraints were obtained from analysis of a 
three-dimensional NOESY-HMQC spectrum recorded at 
a single mixing time on the complex. Hydrogen-bond 
restraints were incorporated for the Watson-Crick base 
pairs in the helical stem of the RNA in the complex. 
Torsion-angle restraints were imposed on selected ribose 
sugars to maintain appropriate puckers. Additional details 
on the restraints sets and bounds are described in the 
Materials and methods section. The input-restraint 
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statistics and their partitioning into several categories for 
the tobramycin-RNA aptamer complex are summarized 
in Table 2. 
Structure calculations 
The refinement strategy used to define the solution 
structures of the tobramycin-RNA aptamer complex is 
outlined briefly below and in more detail in the Materials 
and methods section. The initial starting structures of the 
RNA aptamer contained A-form stem segments and 
stacked bulge and hairpin-loop residues. Tobramycin was 
next positioned at the center of mass of the RNA duplex 
in a randomized orientation. The molecular dynamics cal- 
culations were performed at lOOOK on the entire 
complex, initially with the intermolecular nonbonded 
interactions between tobramycin and RNA turned off, 
and subsequently with the full potential energy function 
turned on during the computations. Seven low-energy 
distance-refined solution structures of the tobramycin 
binding domain (residues 7-21) of the RNA aptamer are 
shown in stereo in Figure 7a while a representative struc- 
ture of the complex is shown in stereo in Figure 7b. 
Structure analysis 
The superpositioned distance-refined structures of the 
tobramycin-RNA aptamer complex (Fig. 7a) exhibit low 
total energy, low root mean square (rms) deviation energy 
gradients and a low van der Waals energy while satisfying 
the NOE-derived distance restraints (Table 2). The tobra- 
mycin binds in the major groove of the RNA aptamer 
spanning residues G9-U12 and G14-Cl8 which are cen- 
tered about the stem-hairpin-loop junction in the complex 
(Fig.7b). The bulged Al9 base (Fig. 8b) and the looped 
out Cl.5 residue (Fig. 8a) are important components of the 
RNA-binding pocket in the tobramycin complex. 
The penetration of the tobramycin molecule into the 
major groove of the RNA aptamer, together with the role 
of the Cl5 base as a flap, are highlighted in views of the 
complex shown in Figure 9a and b. Tobramycin ring III, 
and to a lesser extent ring I, are sandwiched between the 
floor of the major groove and the Cl5 base flap, while ring 
II interacts less intimately (Fig. SC) with the major groove 
of the RNA aptamer in the complex. The intermolecular 
interactions of tobramycin rings III and I with the floor of 
the major groove in the complex are shown in Figure 8c 
and 8d. The relative orientations of the positively charged 
NH,+ groups on the tobramycin and the backbone phos- 
phates on the RNA aptamer in the complex viewed down 
the major groove are shown in Figure 9d. 
The hairpin-loop spanning residues Ull-UlZ-A13-G14- 
ClS-U16 of the RNA aptamer adopt a specific folded con- 
formation on formation of the complex with tobramycin. 
The fold of the U12-A13-G14 segment is stabilized by a 
pair of cross-strand hydrogen bonds (Fig. lOa), as well as 
Table 2 
Statistics of NMR data of the seven refined structures of the 
tobramycin-RNA aptamer complex. 
NMR distance restraints 
RNA aptamer 
Intra-residue 149 
Sequential (Ii-j] = 1) 144 
Long range (Ii-j I> 2) 123 
Hydrogen bond 54 
Tobramycin 
Tobramycin-RNA aptamer 
Structure statistics 
NOE violations 
Number > 0.1 A 
Number > 0.2A 
rms deviations of violations (A) 
Deviations from ideal covalent geometry 
Bond length (A) 
Bond angle (“) 
Impropers (g 
Pairwise rms deviation (A) amongst 
the seven refined structures 
RNA aptamer 
Residues A7-U21 (excluding Cl 5) 
Residues G9-Cl8 (excluding Cl 5) 
Tobramycin 
Residues I, II and Ill 
Tobramycin-RNA aptamer complex 
Tobramycin (I, II and Ill) and 
RNA residues A7-U21 (excluding Cl 5) 
Tobramycin (I, II and Ill) and 
RNA residues G9-Cl8 (excluding Cl 5) 
495 
416 
45 
34 
l-2 
0 
0.014 zk 0.001 
0.008 f 0.001 
2.941 f 0.317 
0.417 f 0.020 
1.98 +_ 0.51 
1.13 f 0.18 
0.80 f 0.28 
2.00 AZ 0.46 
1.24 k 0.20 
stacking of Al3 and G14 purine residues in the complex 
(Fig. 10d). The hairpin-loop Ull and U16 bases align 
through formation of a pair of Wobble hydrogen bonds 
(Fig. 10~) and extend the stem by an additional U*U 
mismatch pair in the complex. 
The most striking feature of the tobramycin-RNA aptamer 
complex is that the aminoglycoside antibiotic is partially 
encapsulated within a channel generated between the floor 
of the major groove and the pyrimidine ring of Cl5 at the 
binding site. Surface representations of the channel and its 
partially encapsulated tobramycin are shown in views 
looking into the major groove in Figure 1 la and 1 lc and 
looking into the minor groove in Figure 1 lb and 1 Id. 
Discussion 
The present study of tobramycin has focused on its 
complex with an RNA aptamer rather than the natural 
ribosomal RNA target because the binding is much tighter 
to the RNA aptamer (nanomolar) than to the ribosomal 
RNA target (millimolar). The decision to work on the 
RNA aptamer with its high-affinity binding for tobramycin 
accounts for the excellent quality of the NMR spectra 
observed for the complex. Previous research identified 
two RNA aptamers that bound to tobramycin with 
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Figure 7 
Structure of the core of the tobramycin-RNA 
aptamer complex. (a) A stereo view of seven 
superimposed distance-refined structures of 
the extended core (residues A7-U21 and 
tobramycin) of the tobramycin-RNA aptamer 
complex. The RNA bases are colored blue 
except for residues Cl 5 and Al 9 which are 
pink, the RNA backbone is orange and the 
bound tobramycin is greeny yellow. The 
superposition was performed on all heavy 
atoms of tobramycin and GQ-Cl8 RNA 
residues excluding Cl 5. (b) A stereo view of 
one representative refined structure of the 
core (residues A7-U21 and tobramycin) of 
the tobramycin-RNA aptamer complex. 
nanomolar affinity [ 111. The present study reports on the 
solution structure of the complex between one such RNA 
aptamer and tobramycin, and efforts are currently under 
way to solve the structure of the other tobramycin-RNA 
aptamer complex. 
Spectral quality 
We have obtained very high quality NMR spectra for the 
tobramycin-RNA aptamer complex as exemplified by the 
narrow and well-resolved imino proton resonances of the 
complex recorded in Figure 2b. The quality of the spectra 
reflect complex formation involving binding of tobramycin 
with sequence and structural specificity and with high 
affinity at a single site on the RNA aptamer. The applica- 
tion of multinuclear multidimensional NMR methods to 
the tobramycin-uniformly 13C,1SN-labeled RNA-aptamer 
complex readily yielded the RNA assignments in the 
complex. We do not have access to isotopically labeled 
tobramycin so the aminoglycoside antibiotic assignments 
in the complex were deduced from standard and 13C-f3- 
tered NMR experiments. Such an approach yielded all the 
nonexchangeable and a few exchangeable proton (NH,+ 
and OH) assignments of tobramycin in the complex. The 
major limitation was the near degeneracy in the chemical 
shifts of several tobramycin nonexchangeable protons that 
restricted somewhat the number of intermolecular NOES 
that could be unambiguously assigned and used in the 
structure calculations for the complex. 
Quality of the refined structures 
We have used a robust computational protocol in our efforts 
to define the solution structure of the tobramycin-RNA 
aptamer complex. There was no bias in the alignment of 
the tobramycin molecules, because they were positioned in 
a randomized orientation at the center of mass of the initial 
RNA conformation at the start of the distance-restrained 
molecular dynamics calculations. This approach placed 
the tobramycin molecules in a randomized orientation 
at the (G6-GB)~(CZO--C22) segment at the start of the 
calculations and resulted in a defined orientation at 
(G9-UlZ)*(ClS-C18) segment at the end of the calcula- 
tions. We also insured that there was no bias in the choice of 
starting conformations within the tobramycin-binding G9- 
Al9 segment of the RNA aptamer in the early stages of the 
molecular dynamics calculations. Thus, Watson-Crick base 
pairing was enforced only for the (Gl-GB)*(CZO-C27) 
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Figure 8 
Intermolecular interaction between tobramycin 
and RNA. (a) The alignment of tobramycin (in 
greeny yellow) within the major groove of the 
(G9-U1O-Ul1-U12)*(G14-C15-U16- 
Al 7-C16) segment in one representative 
refined structure of the tobramycin-RNA 
aptamer complex. (b) A view of 
(A7-G8-G9)*(C18-A19-C20- U21) and 
rings I and Ill of tobramycin in one 
representative refined structure of the 
tobramycin-RNA aptamer complex. This view 
emphasizes the positioning of the bulged Al 9 
base (in pink) relative to its flanking G*C base 
pairs in the complex. Note that the G8*C20 
base is propeller-twisted relative to the 
G9*C18 base pair in the complex. Views of (c) 
tobramycin amino sugar ring III and (d) 
tobramycin nonsugar ring I in face-down 
alignments within the major groove of the RNA 
aptamer helix in one representative refined 
structure of the complex. 
RNA helical segment at the start of the computations and 
Watson-Crick pairing for the (G%UlO)*(A17-C18) seg- 
ment was gradually introduced later in the calculations. 
Snapshots taken at early stages during the trajectory of the 
molecular dynamics calculations at lOOOK established that 
the G9-A19 segment of the RNA aptamer adequately 
sampled conformational space. Finally, no hydrogen- 
bonding restraints were used to restrict the conformation of 
the Ul l-U16 hairpin loop and no intermolecular hydrogen- 
bonding restraints were used to restrict the alignment of the 
tobramycin on the RNA aptamer. 
The conformation of tobramycin in the complex is well 
defined since we observe rms deviation values of 
O.SOA~O.28 (Table 2) following superposition of only the 
aminoglycoside antibiotics within the seven distance- 
refined structures of the complex. Similarly, the G9-Cl8 
segment (excluding the looped-out Cl5 residue) is well 
defined, because we observe rms deviation values of 
1.13Af0.18 (Table 2) following superposition of only this 
RNA segment within the seven distance-refined struc- 
tures of the complex. The finite number of unambiguous 
intermolecular restraints, however, results in a small 
spread in the alignment of the tobramycin within the 
RNA major groove of the complex (Fig. 6a). 
The seven distance-refined structures of the tobramy- 
tin-RNA aptamer complex (entire tobramycin and RNA 
residues A7-U21 excluding (215) exhibit rms deviation 
values in the range 2.0Af0.46 (Table 2). There is a 
spread in the position of the Al9 bulged base amongst the 
relined structures (Fig. 6a), which in turn affects the ori- 
entation of the long helix with respect to the tobramycin- 
binding site. Thus, the rms deviation values reduce to 
1.24A~O.20 (Table 2) for the core of the complex (entire 
tobramycin and RNA residues G9-Cl8 excluding C15). 
Global features of the complex 
The tobramycin molecule binds in a defined orientation 
within the major groove spanning the hairpin-loop-stem 
junction of the RNA aptamer (Fig. 7b). The RNA binding 
site spans a mixture of Watson-Crick (G9*C18 and 
UlO*A17) and mismatch (Ull*U16) base pairs with the 
looped out Cl5 residue being important in the partial 
encapsulation of the bound tobramycin. The tobramycin 
targets the RNA major groove such that amino sugar ring 
II is directed towards the hairpin loop while amino sugar 
ring III is directed towards the Al9 bulged base in the 
complex (Fig. Sa). The Cl5 base is looped out of the helix 
but orients itself as a flap over the tobramycin ring III in 
the complex (Fig. 8a). The Al9 bulged base is displaced 
partially into the major groove and perturbs stacking 
between Watson-Crick aligned G9*C18 and G8*C20 base 
pairs in the complex (Fig. 8b). 
Tobramycin alignment in the complex 
The conformation of tobramycin in the relined structures 
of the complex is defined by the torsion angles about 
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Figure 9 
Tobramycin alignment in the major groove of 
the RNA aptamer. Views (a) looking into the 
major groove and (b) looking down the major 
groove of one representative refined structure 
of the extended core (residues G6-C22 and 
tobramycin) of the tobramycin-RNA aptamer 
complex. These views highlight the positioning 
of tobramycin (in yellow) in a space-filling 
representation within the major groove of the 
RNA backbone (in orange) together with the 
looped out Cl 5 residue (in pink). (c) A 
GRASP view of the tobramycin molecule in 
yellow inserted into the RNA major-groove 
binding pocket closed by the flap-like 
alignment of the Cl 5 base in one 
representative refined structure of the 
complex. (d) A view emphasizing the relative 
positioning of the NHs+ groups on the 
tobramycin (meshed surfaces in blue) and 
RNA backbone phosphates (meshed surfaces 
in pink) in one representative refined structure 
of the complex. 
Figure 10 
Conformation of the U-turn motif of the RNA 
aptamer on formation of the complex. A 
comparision of the RNA fold of (a) the 
U12-A13-G14 turn in one representative 
refined structure of the tobramycin-RNA 
aptamer complex with (b) the corresponding 
fold in the three-nucleotide turn of the anticodon 
loop in the crystal structure of yeast tRNAphe. 
The emphasis is on the hydrogen bond 
between the 2’-OH of U 12 and the N7 of G 14 
across the loop and the potential hydrogen 
bond between the imino proton of U12 and the 
backbone phosphate at the G14-Cl5 step 
across the loop in the tobramycin-RNA 
aptamer complex and its counterpart in the 
crystal structure of yeast tRNAphe . (c) The 
pairing alignment of the Ul 1 l Ul 6 mismatch 
pair in one representative refined structure of 
the complex. (d) Stacking alignment between 
bases in the U12-A13-G14 segment at the tip 
of the hairpin loop in one representative refined 
structure of the complex. 
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Figure 11 
Surface views of one representative refined 
structure of the tobramycin-RNA aptamer 
complex. The RNA surface representation is 
displayed with GRASP33 [43]. Convex and 
concave surfaces are shown in green and 
grey, respectively. The bound tobramycin is 
shown in a stick representation in yellow. The 
pink arrow points to the Cl 5 base which acts 
as a flap to close the binding site. (a) View of 
the binding-site channel and its occupancy 
looking into the major groove of the complex. 
(b) View of the binding-site channel and its 
occupancy looking into the minor groove of 
the complex. Views (c) and (d) are blow ups 
of the binding site derived from (a) and (b), 
respectively. The tobramycin rings are labeled 
I, II and Ill. 
the two glycosidic bonds linking rings III and I and linking 
rings I and II (Fig. la). The III-I linkage is defined by the 
torsion angles III(H1”)-III (Cl”)-0-1 (C6)=-7.8”f 12.1 
and III(Cl”~O-I(C6)-I (H6)=36.9”f4.7, whereas the I-II 
linkage is defined by the torsion angles I(H4)-I 
(C4)-O-II(C1’)=-34.8”f3.6andI(C4~O-II(C1’)-II(H1’)= 
-27.7” f 17.6 amongst the refined structures of the complex. 
This narrow distribution implies that the glycosidic link- 
ages between rings of tobramycin are well defined in the 
refined structures of the complex. 
All three tobramycin rings adopt a chair conformation with 
rings III and I interacting with the RNA major groove in 
the complex to a greater extent than does ring II. The 
amino sugar ring of III interacts with the major groove 
centered about the G9*C18 and UlO*A17 base pairs in 
one representative refined structure of the complex 
(Fig. 8~). The H3” and HS” protons in axial positions and 
the 2”-OH and 4”-OH hydroxyl groups in equatorial posi- 
tions along with the 6”-OH hydroxyl on ring III are 
directed towards the floor of the major groove, while the 
HZ” and H4” protons in axial orientations on ring III 
are directed outwards towards the Cl5residue flap that 
encapsulates the binding site (Fig. 8~). The non-sugar ring 
I interacts face-down with the major groove, spanning 
three base pairs centered about the UlO*A17 base pair in 
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one representative relined structure of the complex 
(Fig. 8d). The Hl, H3 and H5 protons in axial orienta- 
tions on ring I are directed towards the floor of the major 
groove, while the NH,+ groups at the equatorial 1 
(8.11 ppm) and 3 positions are aligned approximately par- 
allel to the floor of the groove (Fig. 8d). The amino sugar 
ring of II lies partially in the major groove with its 2’-NH,’ 
group directed towards the groove. 
We have measured the buried surface area of tobramycin 
and observe that, amongst the distance-refined structures, 
51.8% of its surface is buried (203.0A2~26.2 out of a total 
of 391.7Azk9.7) on complex formation. The buried 
surface area is asymmetrically distributed amongst the 
three rings of tobramycin because sugar ring II is the least 
buried (Fig. SC) in the complex. Tobramycin was cova- 
lently linked to the affinity-chromatography column 
during in vitro selection through the 6’ position of ring II 
[l l] and this linkage may account for the exposure of the 
6’ edge of ring II to solvent in the complex. 
RNA binding pocket 
The binding pocket for tobramycin in the RNA major 
groove involves elements of both the stem and hairpin- 
loop segments, and, indirectly, the adenine bulge of the 
RNA aptamer. The key elements that define the binding 
pocket include the dimensions of the major groove and the 
base-pair edges spanning the G9-U12 and G14-Cl8 seg- 
ments of the RNA, as well as the orientations of the looped- 
out Cl5 base and the bulged Al9 base in the complex. 
The looped-out Cl5 residue is important because it con- 
tributes to the encapsulation of amino sugar ring III and, 
to some extent, non-sugar ring I of tobramycin in the 
complex. Many intermolecular NOES are observed 
between protons of Cl5 and protons on ring III of 
tobramycin in the complex (Table 1). The downfield 
chemical shift of the H5 proton of Cl5 (6.07ppm) is con- 
sistent with the looping of this base out of the helix in the 
complex. The cytosine H6 and Hl’ protons exhibit a sepa- 
ration of 3.12 A+O.OZ amongst the seven refined structures 
of the complex, which may partially explain the observa- 
tion of a strong NOE between this pair of protons in the 
NOESY spectrum of the complex. The Cl.5 residue can 
be replaced by adenine without affecting the specificity 
and high affinity of complex formation. 
The orientation of the adenine base of the bulged Al9 
residue is intermediate between stacked-in and looped- 
out conformations in the refined structures of the complex 
(Figs 7a and 8b). The H8 proton of Al9 is not stacked 
with flanking bases, which accounts for its downfield 
chemical shift position of 8.54ppm in the complex. There 
is a spread in the relative alignments of the Al9 residue 
and this in turn affects the relative orientation of the two 
stem segments that flank it in the complex. Amongst the 
distance-refined structures of the complex, the G9*C18 
base pair in one direction shows minimal propeller twist 
(-1.4”+ 11.3), while a larger propeller twist (10.5Ok36.8) is 
observed for the G8*C20 base pair in the other direction. 
This may account for the fact that the solvent exchange 
characteristics of the imino proton of the 8.20 base pair 
are faster than those of the imino proton of the 9*18 base 
pair in the complex. The Al9 residue can be replaced by 
guanine with no effect on the specificity and high affinity 
of complex formation. 
Intermolecular contacts in the complex 
Previous studies on neomycin inhibition of the hammer- 
head ribozyme have demonstrated the importance of ionic 
interactions for aminoglycoside-RNA complex formation 
[lo]. We have looked for patterns of intermolecular con- 
tacts involving tobramycin NH,’ groups with the RNA in 
the seven distance-refined structures of the complex. On 
average, one to three NH,+ groups interact with backbone 
phosphates and additional contacts are observed to the N7 
atoms of purines amongst the refined structures. Unfortu- 
nately, we have been unable to identify a consistent 
pattern of specific NH;-phosphate ionic contacts amongst 
the seven refined structures at the current resolution of 
structure determination. We also looked for but were 
unable to find a consistent pattern of specific intermolecu- 
lar contacts involving either the hydroxyl groups on the 
tobramycin or the 2’-hydroxyl groups on the RNA in the 
refined structures of the complex. There appears, however, 
to be shape complementarity between the tobramycin and 
its RNA binding pocket in the complex (Figs 7b and 9b). 
Hairpin-loop conformation 
The UlZ-A13-G14 segment of the hairpin loop of the 
RNA aptamer adopts a well-defined conformation in the 
distance-refined solution structures of the complex 
(Fig. 7a). The key features are stacking between purines 
Al3 and G14 (Fig. 10d) and a pair of cross-strand hydrogen 
bonds across the loop (Fig. 10a). One of these hydrogen 
bonds involves the Z-OH of U12 as donor and the N7 of 
G14 as acceptor with H-N distance of 1.9OA+O.l1 for six 
of the seven refined structures of the complex. This hydro- 
gen bonding is supported by the 9.36ppm 2’-OH chemical 
shift of UlZ in the tobramycin-RNA aptamer complex 
(Fig. 2b) which is downfield from the 6.5 ppm value typical 
of Z-OH protons in RNA [Z&23] but has a value similar to 
a slowly exchanging Z-OH resonance (9.34ppm) identified 
in the AMP-RNA aptamer complex [$I-261. The other 
hydrogen bond involves the imino proton of U12 as donor 
and the phosphate at the G14-Cl5 step with a large varia- 
tion in the H-O distances amongst the refined solution 
structures. It is striking that the same fold for the three- 
residue turn has been observed in the heptanucleotide 
anticodon hairpin loop (Fig. lob) and the TvC hairpin 
loop of yeast tRNAphe [27,28]. An even more striking 
resemblance can be observed between the overall hairpin 
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loop of the present tobramycin-RNA aptamer complex 
and that of a phylogenetically conserved hexanucleotide 
hairpin loop in ribosomal RNA [29]. The U-turn motif and 
a looped-out pyrimidine base followed by a mismatch 
closure of the hexanucleotide loop are common features in 
both structures. The G14 residue can be replaced by 
adenine with no effect on the specificity and high affinity 
of tobramycin-RNA aptamer complex formation. 
The Ul’Z-A13-G14 segment and looped-out Cl5 residue 
are flanked by formation of a well defined Ull*U16 mis- 
match pair in the refined structures of the complex. The 
Ull and U16 bases pair through one of two possible 
Wobble pairing alignments as shown in Figure 9c. Wobble 
T*T and UaU mismatch pairings have been identified 
previously in nucleic acids in solution [30,31] and in the 
crystalline state [32,33]. There is extensive stacking 
amongst the loop bases and between the Ull*U16 mis- 
match pair and the adjacent Watson-Crick UlOaA17 stem 
base pair in the complex. The sugar Hl’ proton of U16 
(4.38ppm) is shifted to high field since it is positioned 
directly over the purine ring of G14 in the complex. 
RNA discrimination 
Tobramycin binds with nanomolar affinity to the RNA 
aptamer under investigation [ll]. It is of interest to probe 
whether the solution structure of the complex provides an 
insight into why this sequence was selected and why 
others might be excluded. We believe that some of the key 
factors in the recognition and discrimination are as follows. 
First, the dimensions of the major groove at the tobramycin 
binding site. It appears that the major groove width is 
defined by the pyrimidine*pyrimidine Ull*U16 mismatch 
and the sharp turn at UlZ-A13-G14 segment which orients 
U12 in the complex. The bulged Al9 residue which is par- 
tially displaced into the major groove, also contributes to 
the width of this groove. Second, the sequence composi- 
tion and size of the hairpin loop. The tobramycin binding 
site encompasses the hairpin loop of the RNA aptamer and 
there appears to be a key requirement for the sequence to 
be Ull-UlZ-A13-R14-NE- U16, where R has to be a 
purine and N can be any base. Third, the flap formed by 
residue 1.5. The looping out of Cl5 (or A15 following sub- 
stitution) and wrapping around the substrate was a unique 
and unexpected feature of the complex. Fourth, the major 
groove base-pair edge at the binding site. The floor of the 
major groove at the tobramycin binding site consists of the 
sequential edges of the Watson-Crick G9*C18 and 
UlOaA17 base pairs, the Wobble Ull*U16 mismatch pair 
and the UlZ*phosphate interaction. This represents a 
defined and unique combination which could provide an 
optimal fit for the bound tobramycin. The fifth and final 
factor likely to be central to recognition and discrimination 
is the specific intermolecular contact involving NH,+ and 
OH protons on tobramycin and phosphate, purine N7 and 
uracil 04 base edges and Z-OH protons on RNA. The 
ensemble of solution structures of the complex do not 
provide consistent intermolecular contacts involving these 
groups, but these could emerge from a higher resolution 
structure determination of the complex. An effort is under 
way to achieve this goal on the basis of structural studies of 
a related tobramycin-RNA aptamer complex [l l] currently 
under investigation in our laboratory. 
Significance 
Our knowledge of aminoglycoside antibiotic-RNA recog- 
nition to date has been restricted to the identification of 
binding sites for these saccharide antibiotics on ribosomal, 
catalytic intron, ribozyme and viral RNAs [S-lo]. The 
aminoglycosides bind RNA with high affinity and speci- 
ficity, with the RNA binding pockets discriminating 
between closely related family members. Our present 
study has defined structural features associated with the 
binding of tobramycin to a stem-loop junction in an RNA 
aptamer identified through in vitro selection [ill. The 
tobramycin binds site-specifically to the RNA major 
groove, and a significant segment of the antibiotic is 
encapsulated between the floor of the major groove and a 
looped-out cytosine residue that forms a flap over the 
binding pocket. We have been unable to identify specific 
ionic contacts between the charged NH,+ groups on the 
tobramycin and phosphates on the RNA aptamer that 
would represent common recognition elements amongst 
all the relined structures of the complex at the current res- 
olution. Although the present study greatly expands our 
knowledge of saccharide-RNA recognition, still higher 
resolution data are required in order to identify potential 
specific intermolecular contacts at the interface of the 
complex. We have observed common features in the 
RNA conformation between the tip of the hairpin loop of 
the RNA aptamer in the tobramycin complex reported in 
this study and the tip of the anticodon and T@ hairpin 
loops in yeast tRNAphe [27,28]. Indeed, there are striking 
similarities in the fold of our hexanucleotide hairpin-loop 
conformation in the tobramycin-RNA aptamer complex 
and the fold reported for a phylogenetically conserved 
hexanucleotide loop in ribosomal RNA [29]. This suggests 
that the binding site for tobramycin characterized in this 
study may represent a recurring scaffold for aminoglyco- 
side antibiotic-binding sites on natural RNA sequences. 
Materials and methods 
Sample preparation 
The 27-mer RNA aptamer and its single base-substitution analogs were 
prepared either by chemical synthesis on an Applied Biosystems syn- 
thesizer or by in vitro transcription using T7 transcription and synthetic 
DNA templates [34,351. The RNA oligomers were ethanol precipitated 
and purified using 20% denaturing polyacrylamide-gel electrophoresis 
(containing 7 M urea). The RNA oligomer was monitored by UV shadow- 
ing, cut and electroeluted using an elutrap (Schleicher and Schuell, Inc). 
The eluted RNA was ethanol-precipitated and equilibrated with NMR 
buffer (10 mM phosphate, pH 6.6) by spinning through an Amicon cen- 
tricon (3 kDa cut off), with the procedure repeated five to seven times. A 
50 ml transcription yields about 15 mg of RNA. The same transcription 
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conditions were used for uniformly ‘sC,r5N-labeled RNA except that r3C 
and 15Nelabeled nucleoside triphosphates (NTPs) were used instead of 
unlabeled counterparts. The i3C,15N-labeled NTPs were isolated from 
an Escherichia co/i strain overexpressing ribosomal RNA grown in 
minimum medium containing 13C glucose and 15N ammonium sulfate as 
carbon and nitrogen sources [36). 
A tobramycin (Fluka, NY) stock solution (100 mM) was prepared by dis- 
solving the antibiotic in an aqueous solution adjusted to pH 6.8. This 
stock solution was gradually added to the RNA aptamer and complex 
formation followed by recording imino proton spectra. 
NMR spectroscopy 
NMR spectra were collected on Varian Unity Plus 600MHz and 
500MHz NMR spectrometers. A detailed description of the multi- 
nuclear multidimensional NMR experiments used for data collection 
have been outlined in previous publications from our laboratory on 
l igand-RNA aptamer complexes [25,37]. The NMR data were 
processed on SUN work stations using VNMR software and analyzed 
using the FELIX program (Molecular Simulations Inc). The three-dimen- 
sional NMR data were processed using NMRPipe and PIPP programs 
[38,391. Proton chemical shifts were referenced to 2,2-dimethyC2- 
silapentane-5sulfonate (DSS) while carbon and nitrogen chemical 
shifts were indirectly referenced to DSS and ammonia, respectively. 
Input restraints 
Input distance restraints involving nonexchangeable protons were 
derived from NOE build-up experiments in NOESY spectra on the 
complex recorded at mixing times of 50, 100, 150 and 200 ms in D,O 
buffer at 25°C. The volume integrals of each non-overlapped cross- 
peak were measured and plotted against the mixing time as build-up 
curves and fitted to second-order polynomials. Inter-proton distances 
were calculated from the initial build-up rates using the slopes of the 
cytosine and uracil H5-H6 intra-residue cross-peaks as a reference, 
calibrated to a 2.45 A distance. The distance restraints were assigned 
an upper and lower bounds range of 15% for well-resolved cross- 
peaks, 25% for slightly overlapped cross-peaks, 30% for cross-peaks 
involving adenine H2 protons and 40% for significantly overlapped 
cross-peaks. In addition, very weak cross-peaks in 300 ms mixing time 
NOESY spectra were given upper bounds of 6.5A. Interproton dis- 
tance restraints involving exchangeable protons in the complex were 
derived from NOESY spectra recorded at 190 and 200ms mixing 
times in H,O buffer at 5°C. The inter-proton distances were calibrated 
against the uracil imino to adenine H2 distance of 2.93A as reference. 
The distance restraints were assigned an upper and lower bounds 
range of 250/o, which was increased to 35% for restraints involving 
amino protons. Additional restraints were obtained from analysis of 
cross-peaks in a NOESY-HMQC data set on the complex recorded at 
a mixing time of 120 ms in D,O buffer at 25°C. These restraints were 
treated in a more qualitative manner and classified as strong 
(2.65Af0.85) medium (3.40A+1.60) or weak (4.15Af2.35). 
Watson-Crick pairing alignments were imposed for the duplex portion 
of the RNA (residues l-8 and 20-27) in the initial stages of the calcula- 
tions and for the short stem segment (residues 9-l 0 and 17-l 8) in the 
later stages of the calculations. These hydrogen-heavy atom distances 
were taken from the standard base-pair geometries of nucleic acids 1401 
and were assigned values of 2.OAk0.2. The backbone of the first four 
base-pairs (Gl-A4 and U24-C27) of the longer duplex stem was 
restricted to that of A-form duplex RNA during the computations. 
A few sugar pucker restraints were used based on an analysis of 
phase-sensitive-COSY spectra of the complex in D,O buffer at 25°C. 
The presence of strong Hl’-H2’ coupling cross-peaks was interpreted 
as CP’-endo family of sugar puckers, whereas the absence of 
Hl ‘-HP’coupling cross-peaks were interpreted as C3’-endo family of 
sugar puckers and translated to the corresponding values and ranges 
for the sugar endocyclic torsion angles [401. Residues Gl, Al 7, Cl 8 
and C27 which exhibit weak to medium intensity Hl’-H2’ coupling 
cross-peaks were excluded from the the C3’-endo pucker range and 
restricted to values of P=108°-2160. All other residues were left 
unrestrained during the computations. 
The six-membered rings of tobramycin were restricted to a chair pucker 
early in the computations but this restriction was released at later stages 
in the computations on the complex. 
Starting structures of the complex 
The starting structure of tobramycin was generated using the INSIGHT 
program with the Ill-l linkage defined by the torsion angles III(Hl”)- 
lII(Cl”)-O-I(C6)=-7.8° and III(C1”)-O-I(C6)-I(H6)=-2.4”, while 
the I-II linkage was defined by the torsion angles I(H4)-I(C4)- 
0-ll(Cl’)= -12.0’ and I&4)-O-II&l’)-II(Hl’)= 1.9”. The starting 
structure of the RNA aptamer was A-form in the stem, bulge and loop 
regions. Watson-Crick base pairing was maintained in the (Gl -G8)* 
(C20-C27) stem segment throughout the calculations and introduced 
at the (G9-Ul O)*(Al7-C18) stem segment at a later stage in the cal- 
culations. The tobramycin molecule was placed in a randomized orien- 
tation at the center of mass of the RNA to generate 50 starting 
structures of the complex. 
Distance-restrained molecular dynamics simulations 
Restrained molecular dynamics calculations were performed on the 
tobramycin-RNA aptamer complex on the basis of on a simulated 
annealing protocol in vacuum with a distance-dependent dielectric 
constant using the X-PLOR program [41]. All intermolecular non- 
bonded interactions were turned off during the initial stages of the 
refinement. The system was heated to lOOOK and then maintained at 
this temperature over a period of 230~s during which all distance 
restraints were added in a gradual manner, with shorter range restraints 
added first followed by increasingly longer range restraints in terms of 
the primary sequence of the system. A single weak restraint was initially 
employed between tobramycin and the RNA aptamer, to prevent the 
molecules from migrating apart during the simulation. The weights for 
both distance and dihedral restraints were grown to a value of 100 kcal 
mol-’ A-* and 100 kcal mol-’ rad-2, respectively, during this period. 
The molecular dynamics calculations were continued at 100OK for 
another 20 ps followed by cooling from 1000 K to 50 K over 20 ps and 
subsequent minimization. The nonbonded interactions between 
tobramycin and the RNA were added during the second phase of the 
refinement. The van der Waals interaction between molecules was 
introduced gradually in cycles of minimization, with the weight of this 
term growing from 1 O-lo to 1. This was followed by 5 ps of molecular 
dynamics at 200K. The electrostatics term between molecules was 
next gradually introduced in cycles of dynamics with the weight of this 
term growing from 1 O-lo to 1. The system was then cooled from 200K 
to 50K during 20 ps of dynamics followed by minimization. The result- 
ing structures were heated to 300K and retained at this temperature 
for 20 ps with all restraints involving Al 9 base protons initially turned 
off and then grown in during this period. This was done in an attempt to 
better characterize the position of A19 in the complex. The dynamics 
was continued for an additional 20 ps, during which the system was 
cooled from 300 K to 50 K, followed by minimization. Seven best struc- 
tures of the complex were selected for analysis based on the lowest 
NOE violations, acceptable covalent geometry and favorable van der 
Waals energy. 
Structure analysis 
The helical parameters of the RNA were analyzed using the CURVES 
program [42]. Color figures were prepared using the INSIGHT11 
program (Molecular Simulations Inc.) and the GRASP program 1431. 
Coordinates deposition 
The coordinates of the tobramycin-RNA aptamer complex (accession 
number: 1TOB) have been deposited with the Protein Data Bank, 
Brookhaven National Laboratory, Upton, New York, 11923, USA, from 
whom copies can be obtained. 
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Supplementary material 
Supplementary material published with this paper on the internet 
includes: two tables of proton and carbon chemical shifts of tobramycin 
and RNA aptamer protons and carbons in the tobramycin-RNA aptamer 
complex and seventeen figures of NMR data on the tobramycin-RNA 
aptamer complex in Ha0 and D,O solution. 
Acknowledgements 
This research was funded by NIH grant GM 54377 to DJP. We thank 
Weijun Xu for preparation of the T7 polymerase and uniformly labeled 
13C.15N nucleoside triohosohates; David Live for his helo with NMR data 
collection and processing and John Hubbard for help in the preparation of 
color figures. Multinuclear multidimensional NMR software was kindly 
provided by Frank Delaglio and Daniel Garrett of the Laboratory of Chemical 
Physics, NIDDK, NIH. 
References 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
6. 
9. 
IO. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
16. 
19. 
20. 
Tanaka, N. (1965). Aminoglycoside antibiotics. Antibiotics Ill: 
mechanism of action of antimicrobial and antitumor aoents (Corcoran, 
J.W. & Hahn, F.E. eds), pp. 340-364, SpringerVerla9, Berlin, Germany. 
LeGoffic, F., Capmau, M.L., Tangy, F. & Baillarge, M. (1979). Mechanism 
of action of aminoglycoside antibiotics. Eur. J. Biocbem. 102, 73-61. 
Gale, E.F., Cundliffe, E., Reynolds, P.E., Richmond, M.H. &Waring, 
M.J. (1961). The Molecular Basis of Antibiotic Action. pp. 402-547, 
John Wiley &Sons, London, UK. 
Cundliffe, E. (1967). On the nature of antibiotic binding sites in 
ribosomes. Biochimie 69, 863-669. 
Moazed, D. & Noller, H.F..(1967). Interaction of antibiotics with 
functional sites in 16s ribosomal RNA. Nature 327,369-394. 
Recht, M.I., Fourmy, D., Blanchard, SC., Dahlquist, K.D. & Puglisi, J.D. 
(1996). RNA sequence determinants for aminoglycoside binding to an 
A-site rRNA model oligonucleotide. J. Mol. Viol. 262, 421-436. 
von Ahsen, U., Davies, J. & Schroeder, R. (1991). Antibiotic inhibition 
of group I ribozyme function. Nature 353, 366-370. 
von Ahsen, U. & Noller, H.F. (1993). Footprinting the sights of 
interaction of antibiotics with catalytic group I intron RNA. Science 
260,1501-1503. 
Zapp, M.L., Stern, S. & Green, M.R. (1993). Small molecules that 
selectively block RNA binding of HIV-1 rev protein inhibit rev function 
and viral production. Cell 74, 969-978. 
Clouet-d’Orval, B., Stage, T.K. & Uhlenbeck, O.C. (1995). Neomycin 
inhibition of the hammerhead ribozyme involves ionic interactions. 
Biochemistry 34, 11 166-l 1190. 
Wang, Y. & Rando, R.R. (1995) Specific binding of aminoglycoside 
antibiotics to RNA. Chemistry & Biology 2, 261-290. 
Lato, SM., Boles, A.R. & Ellington, A.D. (1995). In vitro selection of 
RNA lectins: usino combinatorial chemistry to interpret ribozvme 
evolution. Chemi.&y & Biology 2, 291-393. . 
Wallis. M. G., von Ahsen, U., Schroeder, R. & Famulok, M. (1995). A 
novel RNA structure for neomycin recognition. Chemistry & Biology 2, 
543-552. 
Del Bene, V.E., & Farrar, Jr., W.E. (1972). Tobramycin: in vitro activity 
and comparison with kanamycin and gentamicin. Antimicr. Ag. 
Chemoth. 1,340. 
Fiala. R.. Jiana. F. & Patel. D.J. (1996). Direct correlation of -. 
exchangeable and nonexchangeable protons in purine bases in 
13C,‘aN-labeled RNA using HCCNH-TOCSY experiment. J. Am. 
Chem.Soc. 118,689-695. 
Simorre. J.P., Zimmermann. G.R., Mueller, L. & Pardi, A. (1996). 
Correlation of guanosine exchangeable and nonexchangeable protons 
in ‘3C-/IaN-labeled RNA with an HNC-TOCSY-CH experiment. 
J. Biomol. NMR 7, 153-l 56. 
Sklenar, V., Dieckmann, T., Butcher, SE. & Feigon, J. (1996). Through 
bond correlation of imino and aromatic resonances in 13C,1aN-labeled 
RNA via heteronuclear TOCSY. J. Biomol. NMR 7, 63-87. 
Patel, D.J., Kozlowski, S.A., Nordheim, A. & Rich, A. (1962). Right- 
handed and left-handed DNA: studies of B-DNA and Z-DNA by using 
proton nuclear Overhauser effect and phosphorus NMR. Proc. Nat/. 
Acad. Sci. USA. 79, 1413-1417. 
van Pelt, J.E., Moobery, E.S. & Frey, P.A. (1990). ‘H, 13C and alP 
NMR spectral assignments of tobramycin, 2”-(adenosine-5’- 
phosphoryl)-tobramycin and 2”-(adenosine-5’-thiophosphoryl)- 
tobramycin. Arch. Biochem. Biophys. 280, 264-291. 
Koyima, G., litaka, Y., Maeda, K. & Umezawa, H. (1966). The crystal 
structure of kanamycin. Tetrahedron Lett. 15, 1875-l 879. 
21. 
22. 
23. 
24. 
25. 
26. 
27. 
26. 
29. 
30. 
31. 
32. 
33. 
34. 
35. 
36. 
37. 
38. 
39. 
40. 
41. 
42. 
43. 
Pedersen, L.C., Benning, M.M. & Holden, H.M. (1995). Structural 
investigation of the antibiotic and ATP-binding sites in kanamycin 
nucleotidyltransferase. Biochemistry 34, 13305-l 331 1. 
Cheong, C., Varani, G. & Tinoco, Jr. I. (1990). Solution structure of an 
unusually stable RNA hairpin, 5’-GGAC(UUCG)GUCC. Nature 346, 
660-682. 
Allain. F.H.T. & Varani, G. (1995). Structure of the Pl helix from group - 
I self-splicing introns. J. Mol. Biol. 250, 333-353. 
Jiana, F.. Kumar, R.A., Jones, R. & Patel. D.J. (1996). Structural basis 
of RNA folding and recognition in an AMP-RNA aptamer complex. 
Nature 382, 183-I 86. 
Jiang, F., Fiala, R., Live, D., Kumar, R.A. & Patel, D.J. (1996). RNA 
foldina toooloav and intermolecular contacts in the AMP-RNA 
aptamer corn&x. Biochemistry 40, 13250-l 3266. 
Dieckmann. T.. Suzuki, E.. Nakamura, G. K. & Feiaon, J. (1996). 
Solution structure of an ATP-binding RNA aptam% reveals a novel 
fold. RNA 2, 628-640. 
Kim, S.H., et al., & Rich, A. (1974). Three-dimensional tertiary structure 
of yeast phenylalanine transfer RNA. Science 185, 435-439. 
Robertus, J.D., et a/., & Klug, A. (1974). Structure of yeast 
phenylalanine tRNA at 3A resolution. Nature 250, 546-551. 
Huang, S., Wang, Y-X. & Draper, D.E. (1996). Structure of a 
hexanucleotide RNA hairpin loop conserved in ribosomal RNAs. 
J. Mol. Biol. 258, 306-321. 
Kouchakdjian, M., Li., B.F., Swann, P.F. & Patel, D.J. (1988). 
F’wimidine-pvrimidine base pair mismatches in DNA: an NMR studv of 
T;T pairing i neutral pH anb C*C pairing at acidic pH in . 
dodecnucleotide duplexes. J. Mol. Biol. 200, 139-l 55. 
Wang, Y-X., Huang, S. & Draper, D.E. (1996). Structure of a U*U pair 
within a conserved ribosomal RNA hairpin. Nucleic Acids Res. 24, 
2666-2672. 
Bayens, K.J., De Bondt, H.L. & Holbrook, S.R. (1995). Structure of an 
RNA double helix including uracil-uracil base pairs in an internal loop. 
Nat. Struct. Biol. 2, 56-62. 
Rould, M.A., Perona, J.J. & Steitz, T.A. (1991). Structural basis of 
anticodon loop recognition by glutaminyl-tRNA synthetase. Nature 
352,213-216. 
Milligan, J.F., Groebe, D.R., Witherall, G.W. & Uhlenbeck, O.C. 
(1967). Oligoribonucleotide synthesis using T7 RNA polymerase and 
synthetic DNA templates. Nucleic Acids Res. 15, 6763-8798. 
Wyatt, J.R., Chastain, M. & Puglisi, J.D. (1991). Synthesis and 
purification of large amounts of RNA oligonucleotides. Biotechniques 
11,764-769. 
Nikonowicz, E.P., Sirr, A., Legault, P., Jucker, F.M., Baer, L.M. & Pardi, 
A. (1992). Preparation of 13C and 15N labeled RNAs for heteronuclear 
multi-dimensional NMR studies. Nucleic Acids Res. 20, 4506-4513. 
Fan, P., Suri, A.K., Fiala, R., Live, D., & Patel, D.J. (1996). Molecular 
recognition in the FMN-RNA aptamer complex. J. Mol. Biol. 258, 
480-500. 
Delaolio, F.. Grzesiek, S., Vuister. G., Zu. G.. Pfeiffer, J. & Bax, A. 
(1995). NMRPipe: a multidimensional spectral processing system 
based on UNIX pipes. J. Biomol. NMR 6, 277-293. 
Garrett, D.S., Powers, R., Gronenborn, A.M. & Clore, G.M. (1991). A 
common sense approach to peak picking in two, three and four- 
dimensional spectra using automatic computer analysis of contour 
programs. 1. Magn. Reson. 95, 2 14-220. 
Saenger, W. (1964). Principles of Nucleic Acid Structure. Springer 
Verlag, New York. 
Brunger, A.T. (1992). X-PLOR User Manual. (Version 3.1), Yale 
University, New Haven. 
Lavery, R. & Sklenar, H. (1968). The definition of generalized helicoidal 
parameters and axis of curvature for irregular nucleic acids. J. Biomol. 
Sfruct. Dyn. 6, 63-91. 
Nicholls, A., Sharp, K.A. & Honig, B.H. (1991). Protein folding and 
association: insights from the inter-facial and thermodynamic 
properties of hydrocarbons. Profeins 11, 261-296. 
